| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/02/1999 | US5866547 Methods of neuroendocrine regulation of affective disorders |
| 02/02/1999 | US5866160 Human therapy |
| 02/02/1999 | US5866123 Gene encoding cationic amino acid transporter protein |
| 01/31/1999 | CA2244200A1 Use of substituted 2,4-imidazolidinedione compounds as analgesics |
| 01/30/1999 | CA2244435A1 New heterocyclic compounds, their preparation process and the pharmaceutical compounds containing them |
| 01/29/1999 | CA2239266A1 Novel histidine kinase |
| 01/28/1999 | WO1999004237A2 Diagnosis of spongiform encephalopathies using prionins |
| 01/28/1999 | WO1999003890A1 Novel peptides and polypeptides useful for regenerating the nervous system |
| 01/28/1999 | WO1999003878A2 Inhibitors of metalloproteinases, their therapeutic use, and process for the production of the starting compound in their synthesis |
| 01/28/1999 | WO1999003861A1 Fused 1,2,4-thiadiazine derivatives, their preparation and use |
| 01/28/1999 | WO1999003859A1 Novel spiroazabicyclic heterocyclic compounds |
| 01/28/1999 | WO1999003855A1 Piperazine derivatives |
| 01/28/1999 | WO1999003822A1 Bicyclic metabotropic glutamate receptor ligands |
| 01/28/1999 | WO1999003820A1 Tramadol, salts thereof and process for their preparation |
| 01/28/1999 | WO1999003817A2 Aliphatic propargylamines as cellular rescue agents |
| 01/28/1999 | WO1999003479A1 Lipid-based immune modulator composition |
| 01/28/1999 | WO1999003473A1 Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches |
| 01/28/1999 | WO1999003471A1 Improved delivery of multiple doses of medications |
| 01/28/1999 | WO1999003468A1 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
| 01/28/1999 | WO1999003461A1 Oily patches for external use containing diclofenac sodium |
| 01/28/1999 | WO1999003457A1 Spray formulations of antihyperalgesic opiates and method of treating topical hyperalgesic conditions and pruritus therewith |
| 01/28/1999 | WO1999003455A1 Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic and pruritic conditions therewith |
| 01/28/1999 | WO1999003364A1 Nutritional composition for subjects under stress |
| 01/28/1999 | WO1998046636A3 β-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME |
| 01/28/1999 | WO1998046589A3 Indazole amide compounds as serotoninergic agents |
| 01/28/1999 | CA2296687A1 Piperazine derivatives |
| 01/28/1999 | CA2296540A1 Nutritional composition for subjects under stress |
| 01/28/1999 | CA2296310A1 Bicyclic metabotropic glutamate receptor ligands |
| 01/28/1999 | CA2295884A1 Tramadol, salts thereof and process for their preparation |
| 01/28/1999 | CA2295690A1 Lipid-based immune modulator composition |
| 01/28/1999 | CA2294830A1 Fused 1,2,4-thiadiazine derivatives, their preparation and use |
| 01/28/1999 | CA2289055A1 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
| 01/28/1999 | CA2288204A1 Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic and pruritic conditions therewith |
| 01/28/1999 | CA2288132A1 Spray formulations of antihyperalgesic opiates and method of treating topical hyperalgesic conditions and pruritus therewith |
| 01/28/1999 | CA2237155A1 A yak-1 related serine/threonine protein kinase-htlar33 |
| 01/27/1999 | EP0893503A2 Regulator protein from Staphylococcus aureus |
| 01/27/1999 | EP0893499A2 Tetracycline resistance protein from Staphylococcus aureus |
| 01/27/1999 | EP0893498A2 cDNA clone MY1 that encodes a novel human 7-transmembrane receptor |
| 01/27/1999 | EP0892807A1 Gene family associated with neurosensory defects |
| 01/27/1999 | EP0892804A1 Isoxazolidine derivatives |
| 01/27/1999 | EP0892802A1 Spiro(cyclopent(b)indole-piperidines) and n-phenyl-hydrazon intermediates for their preparation, both being acetylcholinesterase and mao inhibitors |
| 01/27/1999 | EP0892796A1 Isatin derivatives as acetylcholinesterase inhibitors and analgesics |
| 01/27/1999 | EP0892793A1 Substituted tetracyclic tetrahydrofuran derivatives |
| 01/27/1999 | EP0892791A1 Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors |
| 01/27/1999 | EP0731792B1 Heterocyclic benzenesulfonylimine derivatives as inhibitors of il-1 action |
| 01/27/1999 | EP0669919B1 Use of dimethylbenzofurans and dimethylbenzopyrans as 5-ht3 antagonists |
| 01/27/1999 | CN1206417A 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives |
| 01/27/1999 | CN1206414A N-acyl-2-substituted-4-(benzimidazolyl-or imidazopyridinyl-substituted pesidues)-piperidines as tachykinin antagonists |
| 01/27/1999 | CN1206347A Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters |
| 01/27/1999 | CN1206010A 5H-thiazole [3,2-a] pyrimidine derivatives |
| 01/27/1999 | CN1041830C Peptide compound |
| 01/26/1999 | US5864041 Process for producing threo-3-(3,4-dihydroxyphenyl)serine |
| 01/26/1999 | US5864036 Substituted imidazole compounds |
| 01/26/1999 | US5863952 Enantiomers of 1-(3,4-dichlorobenzyl)-2-methylaminoindane |
| 01/26/1999 | US5863947 Treating central nervous diseases such as neurological diseases, neurodegenerative diseases, and as antipsychotic, anticonvulsant, analgesic and antiemetic agents |
| 01/26/1999 | US5863935 Synthesis of indole derivatives of heterocyclic compounds for treatment of headaches and migraines |
| 01/26/1999 | US5863934 Use of lofexidine in the treatment of behavioral disorders |
| 01/26/1999 | US5863928 Treatment of psychotic disorders, parkinson's disease; sedatives |
| 01/26/1999 | US5863927 Dextromethorphan and an oxidase inhibitor for treating intractable conditions |
| 01/26/1999 | US5863925 Use of sulbutiamine in the treatment of Parkinson's disease, schizophrenia, alcoholism, and dysthymia |
| 01/26/1999 | US5863924 5ht2b antagonist |
| 01/26/1999 | US5863923 Treatment of anxiety, psychosis, schizophrenia, drug abuse, irritable bowel syndrome |
| 01/26/1999 | US5863922 An analgesics mixture comprising acetaminophen, sedative butalbital and a n-methyl-d-aspartate receptor antagonist selected from dextrorphan, dextromethorphan |
| 01/26/1999 | US5863917 Anxiolytic agent, anticonvulsants, analgesics and neuroprotectives. |
| 01/26/1999 | US5863916 8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/NMDA receptor |
| 01/26/1999 | US5863804 Monoclonal or polyclonal antibodies obtained by administering to an animal a synthetic peptide or a recombinant protein fragment having a partial sequence of t-cadherin, isolating from animal's serum |
| 01/26/1999 | US5863780 A polynucleotide sequence encodes human protein kinase polypeptide; culture product |
| 01/26/1999 | US5863779 UBC7-like ubiquitin-conjugating enzyme |
| 01/26/1999 | US5863559 Oral dosage form for treating migraine |
| 01/26/1999 | CA2166901C 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them |
| 01/26/1999 | CA2166692C Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 01/26/1999 | CA2132829C Novel derivatives of 2,3-dihydro-benzofuranols |
| 01/26/1999 | CA2129505C Novel zirconium salts and their synthesis |
| 01/26/1999 | CA2006511C Percutaneous preparation of tulobuterol |
| 01/26/1999 | CA2000786C 3-piperidinyl-1,2-benzisoxazoles |
| 01/25/1999 | CA2238664A1 Novel regulator |
| 01/25/1999 | CA2238655A1 Cdna clone my1 that encodes a novel human 7-transmembrane receptor |
| 01/23/1999 | CA2238674A1 Novel tetracycline resistance protein |
| 01/23/1999 | CA2238665A1 Novel reductase |
| 01/21/1999 | WO1999002989A1 Chaperone fragments |
| 01/21/1999 | WO1999002701A1 Pak kinase genes and polypeptides and methods of use thereof |
| 01/21/1999 | WO1999002666A2 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses |
| 01/21/1999 | WO1999002556A1 Semaphorin receptors |
| 01/21/1999 | WO1999002546A1 123 human secreted proteins |
| 01/21/1999 | WO1999002529A1 Preparation of oxymorphone, oxycodone and derivatives |
| 01/21/1999 | WO1999002526A1 Tropane analogs and methods for inhibition of monoamine transport |
| 01/21/1999 | WO1999002517A1 6-pyrrolidin-2-ylpyrindine derivatives, their preparation and application in therapy |
| 01/21/1999 | WO1999002516A1 Compounds derived from thophene and benzothiophene, and related utilisation and composition |
| 01/21/1999 | WO1999002506A1 5-(3-phenyl-3-oxo-propyl)-1h-tetrazole derivatives |
| 01/21/1999 | WO1999002503A1 Triazole compounds and the use thereof as dopamine-d3-ligands |
| 01/21/1999 | WO1999002502A2 Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation |
| 01/21/1999 | WO1999002497A2 Pyridine derivatives |
| 01/21/1999 | WO1999002485A1 Branched chain fatty acids, their derivatives and use in the treatment of central nervous system disorders |
| 01/21/1999 | WO1999002189A1 Pharmaceutical compositions comprising an aldose reductase inhibitor and an ace inhibitor |
| 01/21/1999 | WO1999002154A1 Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias |
| 01/21/1999 | WO1999002142A2 Novel composition comprising an ssri and a beta-blocker |
| 01/21/1999 | WO1998024810A3 Vertebrate homologues of unc-53 protein of c. elegans |
| 01/21/1999 | DE19730989A1 Piperazin-Derivate Piperazine derivatives |
| 01/21/1999 | CA2297187A1 Tropane analogs and methods for inhibition of monoamine transport |
| 01/21/1999 | CA2296440A1 5-(3-phenyl-3-oxo-propyl)-1h-tetrazole derivatives |